{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:25:59Z","timestamp":1792887959293,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R019746\/1"],"award-info":[{"award-number":["MR\/R019746\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Global Health Trials scheme"},{"name":"National Institute of Health Research Biomedical Research Centre","id":[{"id":"https:\/\/ror.org\/014ktry78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Great Ormond Street Hospital","id":[{"id":"https:\/\/ror.org\/00zn2c847","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current guidelines recommend that infants born to women with hepatitis C virus (HCV) viremia be screened for HCV antibody at age 18 months and, if positive, referred for RNA testing at 3 years to confirm chronic infection. This policy is based, in part, on analyses that suggest that 25%\u201340% of vertically acquired HCV infections clear spontaneously within 4\u20135 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on 179 infants with HCV RNA and\/or anti-HCV evidence of vertically acquired infection in 3 prospective European cohorts were investigated. Ages at clearance of infection were estimated taking account of interval censoring and delayed entry. We also investigated clearance in initially HCV RNA\u2013negative infants in whom RNA was not detectable until after 6 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clearance rates were initially high then declined slowly. Apparently, many infections clear before they can be confirmed. An estimated 65.9% (95% credible interval [CrI], 50.1\u201381.6) of confirmed infections cleared by 5 years, at a median 12.4 (CrI, 7.1\u201318.9) months. If treatment were to begin at age 6 months, 18 months, or 3 years, at least 59.0% (CrI, 42.0\u201376.9), 39.7% (CrI, 17.9\u201365.9), and 20.9% (CrI, 4.6\u201344.8) of those treated would clear without treatment. In 7 (6.6%) confirmed infections, RNA was not detectable until after 6 weeks and not until after 6 months in 2 (1.9%). However, all such cases subsequently cleared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most confirmed infection cleared by age 3 years. Treatment before age 3, if it was available, would avoid loss to follow-up but would result in substantial overtreatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciac255","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:12:04Z","timestamp":1649481124000},"page":"913-991","source":"Crossref","is-referenced-by-count":24,"title":["Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-3552","authenticated-orcid":false,"given":"A E","family":"Ades","sequence":"first","affiliation":[{"name":"Population Health Sciences, University of Bristol Medical School , Bristol , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Gordon","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol Medical School , Bristol , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Scott","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intira Jeannie","family":"Collins","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Thorne","sequence":"additional","affiliation":[{"name":"Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pembrey","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Chappell","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8nia","family":"Marin\u00e9-Barjoan","sequence":"additional","affiliation":[{"name":"Public Health Department, Universit\u00e9 C\u00f4te d\u2019Azur, Centre Hospitalier Universitaire de Nice , Nice , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Butler","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Ireland at Crumlin and Temple Street , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Indolfi","sequence":"additional","affiliation":[{"name":"Meyer Children\u2019s Hospital and Department Neurofarba, University of Florence , Firenze , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Gibb","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Judd","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"100237","DOI":"10.1016\/j.eclinm.2019.12.007","article-title":"Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis.","volume":"18","author":"Zoratti","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11904-018-0386-z","article-title":"Treatment of hepatitis C during pregnancy\u2014weighing the risks and benefits in contrast to HIV.","volume":"15","author":"Barritt","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3748\/wjg.v22.i4.1382","article-title":"Vertically acquired hepatitis C virus infection: correlates of transmission and disease progression.","volume":"22","author":"Tovo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis.","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","article-title":"Hepatitis C virus infection in children and adolescents.","volume":"4","author":"Indolfi","year":"2019","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cgh.2018.08.080","article-title":"Cost effectiveness of universal screening for hepatitis C virus infection in the era of direct-acting, pangenotypic treatment regimens.","volume":"17","author":"Eckman","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023030705145565400_","volume-title":"Combating hepatitis B and C to reach elimination by 2030","author":"World Health Organization.","year":"2016"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"key":"2023030705145565400_","volume-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","author":"World Health Organization.","year":"2018"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.jhepr.2021.100227","article-title":"Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines.","volume":"3","author":"Malik","year":"2021","journal-title":"JHEP Rep"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series.","volume":"73","author":"European Association for the Study of the Liver.","year":"2020","journal-title":"J Hepatol"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPG.0000000000002814","article-title":"Hepatitis C in 2020: a North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper.","volume":"71","author":"Leung","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MPG.0000000000001872","article-title":"Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.","volume":"66","author":"Indolfi","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/430601","article-title":"Three broad modalities in the natural history of vertically acquired hepatitis C virus infection.","volume":"41","author":"European Paediatric Hepatitis C Virus Network.","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jmv.21480","article-title":"Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.","volume":"81","author":"Shebl","year":"2009","journal-title":"J Med Virol"},{"issue":"2","key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","article-title":"When does mother to child transmission of hepatitis C virus occur?","volume":"90","author":"Mok","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bmj.317.7156.437","article-title":"Tuscany Study Group on Hepatitis C Virus Infection. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1.","volume":"317","author":"Resti","year":"1998","journal-title":"BMJ"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0168-8278(01)00205-7","article-title":"High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind?","volume":"35","author":"Ceci","year":"2001","journal-title":"J Hepatol"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jmv.10405","article-title":"Clinical features and progression of perinatally acquired hepatitis C virus infection.","volume":"70","author":"Resti","year":"2003","journal-title":"J Med Virol"},{"issue":"11","key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1086\/497695","article-title":"A significant sex\u2014but not elective cesarean section\u2014effect on mother-to-child transmission of hepatitis C virus infection.","volume":"192","author":"European Paediatric Hepatitis CVN.","year":"2005","journal-title":"J Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission.","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/QAD.0b013e3282703810","article-title":"HCV\/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?","volume":"21","author":"Marine-Barjoan","year":"2007","journal-title":"AIDS"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.20540","article-title":"Accuracy of HCV RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection.","volume":"78","author":"Polywka","year":"2006","journal-title":"J Med Virol"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF01709250","article-title":"Use of polymerase chain reaction and antibody tests in the diagnosis of vertically transmitted hepatitis C virus infection.","volume":"16","author":"Thomas","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3748\/wjg.v27.i12.1117","article-title":"Cascade of care for children and adolescents with chronic hepatitis C.","volume":"27","author":"Rogers","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"e20173273","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy.","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2018.07.006","article-title":"Perinatal transmission of hepatitis C virus: defining the cascade of care.","volume":"203","author":"Epstein","year":"2018","journal-title":"J Pediatr"},{"issue":"3","key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"e20192482","DOI":"10.1542\/peds.2019-2482","article-title":"Hepatitis C testing among perinatally exposed infants.","volume":"I45","author":"Lopata","year":"2020","journal-title":"Pediatrics"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/ciw026","article-title":"Failure to test and identify perinatally infected children born to hepatitis C virus-infected women.","volume":"62","author":"Kuncio","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(16)00085-4","article-title":"Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.","volume":"387","author":"Indolfi","year":"2016","journal-title":"Lancet"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciac270","article-title":"Overall vertical transmission of Hepatitis C Virus, transmission net of clearance, and timing of transmission","volume":"76","author":"Ades","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1038\/emi.2015.30","article-title":"Is mother-to-infant transmission the most important factor for persistent HBV infection?","volume":"4","author":"Li","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","article-title":"Mechanisms and prevention of vertical transmission in chronic viral hepatitis.","volume":"5","author":"Mavilia","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2023030705145565400_","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/cid\/ciz063","article-title":"Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States.","volume":"69","author":"Chaillon","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac255\/43991995\/ciac255.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/5\/913\/49424751\/ciac255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/5\/913\/49424751\/ciac255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:55:35Z","timestamp":1700409335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/5\/913\/6565752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,4,9]]},"published-print":{"date-parts":[[2023,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac255","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.29.21264077","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,4,9]]}}}